Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients.

[1]  M. Ennis,et al.  Mast cell mediator release in nonasthmatic subjects after endobronchial adenosine challenge. , 2004, The Journal of allergy and clinical immunology.

[2]  H. Kerstjens,et al.  Provocation with adenosine 5′‐monophosphate, but not methacholine, induces sputum eosinophilia , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  S. Anderson,et al.  Indirect airway challenges , 2003, European Respiratory Journal.

[4]  I. Pavord,et al.  New insights into the role of the mast cell in asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  R. Buhl,et al.  A single nasal allergen challenge increases induced sputum inflammatory markers in non‐asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin‐5 , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  T. Out,et al.  Allergen‐induced bronchial inflammation in house dust mite‐allergic patients with or without asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  S. Holgate.  Adenosine provocation: a new test for allergic type airway inflammation. , 2002, American journal of respiratory and critical care medicine.

[8]  R. Buhl,et al.  Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function , 2001, Thorax.

[9]  J. Marín,et al.  Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis. , 2001, The European respiratory journal.

[10]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[11]  P. O'Byrne,et al.  Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers. , 2000, Canadian respiratory journal.

[12]  B. García,et al.  Comparison of allergen‐induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients , 2000, Allergy.

[13]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[14]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[15]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[16]  M. W. Jensen,et al.  A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients. , 1999, American journal of respiratory and critical care medicine.

[17]  Miadonna,et al.  Nasal response to a single antigen challenge in patients with allergic rhinitis — inflammatory cell recruitment persists up to 48 hours , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  P. Forsythe,et al.  Adenosine, mast cells and asthma , 1999, Inflammation Research.

[19]  J. Fahy,et al.  The effect of methacholine challenge on the cellular composition of induced sputum. , 1999, The Journal of allergy and clinical immunology.

[20]  V. Brusasco,et al.  Effect of methacholine challenge on cellular composition of sputum induction , 1999, Thorax.

[21]  K. Chung,et al.  Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. , 1999, American journal of respiratory and critical care medicine.

[22]  Welker,et al.  Changes in sputum composition during sputum induction in healthy and asthmatic subjects , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  H. Magnussen,et al.  Changes in sputum composition between two inductions performed on consecutive days. , 1998, Thorax.

[24]  M. Andersson,et al.  Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2-macroglobulin. , 1997, Thorax.

[25]  J. Corren.  Allergic rhinitis and asthma: how important is the link? , 1997, The Journal of allergy and clinical immunology.

[26]  S. Holgate,et al.  Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. , 1995, American journal of respiratory and critical care medicine.

[27]  D. Broide,et al.  Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. , 1991, The Journal of allergy and clinical immunology.

[28]  P. Howarth,et al.  Airway inflammation and atopic asthma: a comparative bronchoscopic investigation. , 1991, International archives of allergy and applied immunology.

[29]  S. Holgate,et al.  Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma. , 1988, Clinical science.

[30]  S. Durham,et al.  Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction. , 1985, The Journal of allergy and clinical immunology.

[31]  S. Holgate,et al.  Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release. , 1985, The Journal of allergy and clinical immunology.

[32]  M. Plaut.  Histamine, H1 and H2 antihistamines, and immediate hypersensitivity reactions. , 1979, The Journal of allergy and clinical immunology.